MARKET

VANI

VANI

Vivani Medical
NASDAQ
1.260
+0.030
+2.44%
After Hours: 1.290 +0.03 +2.38% 18:24 02/06 EST
OPEN
1.240
PREV CLOSE
1.230
HIGH
1.290
LOW
1.230
VOLUME
221.87K
TURNOVER
--
52 WEEK HIGH
1.920
52 WEEK LOW
0.9054
MARKET CAP
91.92M
P/E (TTM)
-2.8526
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VANI last week (0126-0130)?
Weekly Report · 5d ago
Vivani’s Cortigent presents 6-year results for Orion system at NANS 2026
TipRanks · 01/29 12:41
Vivani's Brain Implant Helps Blind Patients See Light And Movement In 6-Year Study
Benzinga · 01/29 12:35
Cortigent Reports Promising Six-Year Results for Orion Visual Prosthesis
Reuters · 01/29 12:30
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
Barchart · 01/29 06:30
Major Insider Move Signals Growing Confidence in Vivani Medical
TipRanks · 01/29 02:01
Vivani Medical Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares
Reuters · 01/28 15:01
Vivani Medical Announces Equity Offerings to Fund Pipeline
TipRanks · 01/27 21:31
More
About VANI
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.

Webull offers Vivani Medical Inc stock information, including NASDAQ: VANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VANI stock methods without spending real money on the virtual paper trading platform.